Le Lézard

News by subject: HEALTH

1 2 3 4 5 6 7 8 9 10

Today

03:05
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed new...


17 january 2022

18:00
Medicenna Therapeutics Corp. ("Medicenna" or "the Company") , a clinical stage immuno-oncology company, today announced that Mann Muhsin has resigned as Chief Medical Officer of the Company to assume a position closer to home. Martin Bexon, MBBS, who...

08:20
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's...

07:30
Claritas Pharmaceuticals, Inc. (the "Company" or "Claritas") today announced that it has signed a Letter of Intent dated January 17, 2022 (the "LOI") with Salzman Group, Inc. (a Delaware corporation), Salzman Group, Ltd. (an Israeli corporation),...


14 january 2022

17:40
Ontario's hospitals, long-term care (LTC) and home care services face critical and growing staffing crises. Our province's health care system is not on the brink of crisis, it is in crisis. It is not an overstatement to describe a number of...

10:40
Humanitarian organization Mission Aviation Fellowship (MAF) supports many rural communities in remote Papua New Guinea. In late 2021, there were many happy faces when Alberta native, MAF pilot Ryan Cole, did a test landing at the Mui airstrip in...

07:30
Avicanna Inc. ("Avicanna" or the "Company") , a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based...


13 january 2022

12:25
The Ontario Health Coalition issued a statement today demanding that the Ford government explain what it is going to do about the spiralling crisis in Ontario's long-term care homes and hospitals, and answer for their lack of preparedness. "The...

08:30
Assure Holdings Corp. (the "Company" or "Assure") , a provider of intraoperative neuromonitoring services ("IONM"), announced that its remote neurology business, which launched in 2021, performed more than 2,100 remote neurology managed cases during...

08:00
Two foundations are coming together to improve the health of our community. The Lachine Hospital Foundation is integrating with the McGill University Health Centre (MUHC) Foundation to Dream Big for Lachine Hospital. Under one umbrella, we can...


12 january 2022

17:00
Adagio Therapeutics, Inc., , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for...

08:00
In business for 20 years, Body Energy Club is the leading health supplement and vitamin retailer in Western Canada, with additional locations established in Hollywood, California in 2017Levitee Nutraceuticals, a division of Levitee Labs, brand MONKE...

07:00
Wesana granted pre-IND meeting with FDA, currently set for March 11, 2022Wesana Clinics exhibited a record quarter of billings, new patient visits, telemedicine utilization, overall patient appointments, and ketamine administrations New flagship...

01:00
January 12, 2022 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today provided an update on the fourth-quarter 2021 and full-year 2021 financial results. Group sales for the quarter are...


11 january 2022

09:30
Kizmet Impact Capital ("Kizmet" or the "Company"), an impact investment fund intending to become one of the first publicly-traded funds of its kind by listing on the NEO Exchange, is pleased to announce its launch. Kizmet is focused on democratizing...

07:00
Wesana Health Holdings Inc.  ("Wesana" or the "Company") , a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that the U.S Food and Drug...

06:30
Pure Gold Mining Inc. ("PureGold" or the "Company"), announced today proactive measures taken in response to the small but increasing number of positive Covid-19 cases at the Company's PureGold Mine over the last several days. The Company has...

04:35
Following food authority EFSA's ban of food additive titanium dioxide (TiO2), Blue California, the producer of natural science-based ingredients, launched novel food-grade whitening agents as a clean-label alternative to replacing potential health...


10 january 2022

14:00
LifeLabs is pleased to share that four new individuals have joined its board of directors. The recently appointed board members possess a variety of exceptional experience and skills in the fields of health care, technology, and business operations....

09:00
Shanghai Junshi Biosciences Co., Ltd. ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. ("Coherus") today announced that Coherus...

08:30
Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary dermal technologies, announced that it has received a Clinical Trial Authorization (CTA) in the Netherlands to...

07:30
Acerus Pharmaceuticals Corporation (the "Company" or "Acerus") today announced the signing of an agreement with Verity Pharmaceuticals ("Verity Pharma") for the exclusive rights to promote NATESTO in Puerto Rico....

07:00
Today, TELUS Health launched its digital Virtual Pharmacy service to help improve medication adherence by offering Canadians the opportunity to set up automatic refill reminders for prescription medications that are shipped directly to their...

07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its participation in the H.C. Wainwright BioConnect 2022...

06:00
Neoleukin Therapeutics, Inc., "Neoleukin" , a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will present at the...


7 january 2022

07:05
Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar's...

07:00
ProMIS Neurosciences, Inc. , a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today...


6 january 2022

16:25
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, wishes to clarify certain disclosures in its press release...

12:00
Lui Franciosi will be monitoring the safety and efficacy of nebulized heparin for the treatment of SARS-CoV-2, i.e., COVID-19. There is suggestion that unfractionated heparin has the potential to reduce mortality in COVID-19 patients. The virus...

09:00
Aequus Pharmaceuticals Inc. , ) ("Aequus" or the "Company"), a specialty pharmaceutical company announced today that it has submitted a New Drug Submission (NDS) application to Health Canada for preservative-free bimatoprost 0.03% eye drops termed...

08:05
Field Trip Health Ltd. ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy...

07:00
VitalHub Corp. (the "Company" or "VitalHub") is pleased to announce a significant licensing transaction of subsidiary Intouch with Health's ("Intouch") patient flow platform to Royal Berkshire NHS Foundation Trust (the "Trust" or "Royal Berkshire")....

04:00
Juva Life Inc. ("Juva Life," "Juva" or the "Company"), a life sciences portfolio company with operations in cannabis production and distribution as well as pharmaceutical research and development, announced today the advancement of JUVA-019 from...


5 january 2022

19:30
Core One Labs Inc. , , (the "Company" or "Core One") applauds Health Canada for its recent amendment to the Special Access Programme (SAP), which will now allow physicians to request patient access to psychedelic treatments, including...

16:20
Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to report the successful completion...

16:00
Six million Canadians will meet the criteria for addiction in our lifetimes. COVID-19 has intensified the problem. Opioid-related deaths surged 25% in Ontario in the first few months of the pandemic and continue to be at a crisis point. Premiering...

12:45
North York General Hospital (NYGH), Seneca and the North York Toronto Health Partners are once again partnering to open a COVID-19 vaccination clinic to serve North York residents. Beginning this week, anyone aged 30 or older who is eligible to...

12:00
Franciosi Consulting Ltd. will be performing structure activity analyses of published beta-adrenergic receptor antagonists (a.k.a. beta blockers) as potential new treatments for essential tremor. These antagonists were previously taken to the...

09:00
Baycrest Project and Construction Management today announced that they have been granted the Certificate of Recognition (CORtm) by the Infrastructure Health and Safety Association (IHSA). By receiving the CORtm accreditation, Baycrest has...

05:35
Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing...

03:00
KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that Corey Hilmas, MD, PhD has...

02:30
Covis Pharma Canada Ltd. is pleased to announce that it has entered into an Exclusive Promotion and Distribution Agreement with Novartis Pharmaceuticals Canada Inc. ("Novartis"), whereby Covis has been appointed as Novartis' exclusive partner to...


4 january 2022

16:05
Bright Minds Biosciences ("Bright Minds," "BMB" or the "Company") , a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Ian McDonald, Chief...

10:05
VAXIL BIO LTD. ("Vaxil" or the "Company") , an innovative immunotherapy biotech company is pleased to provide an update on the results of our in vivo efficacy study for our licensed P-Esbp-DOX, a novel anti-cancer drug, first disclosed in our press...

08:20
Mindset Pharma Inc. ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs,...

08:05
Knight Therapeutics Inc. ("Knight" or "the Company") announced today that its Colombian affiliate, Biotoscana Farma S.A. has obtained INVIMA approval for Lenvima® (lenvatinib), the orally available multiple receptor tyrosine kinase inhibitor...

07:35
Biogen Inc.  and Ionis Pharmaceuticals, Inc. today announced that Biogen exercised its option to obtain from Ionis a worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB115/ION306....

07:30
Claritas Pharmaceuticals, Inc. (the "Company" or "Claritas") today outlined the Company's plans for developing R-107, the Company's nitric oxide-releasing compound, for multiple clinical indications. Claritas' Development Strategy for R-107...

07:25
Arch Biopartners Inc. ("Arch Biopartners", "Arch" or the "Company") , a clinical stage company developing new drug candidates for treating organ damage caused by inflammation, announced today that the Research Ethics Board at the Sunnybrook Research...

07:00
Second published study to demonstrate the potential therapeutic utility and mechanism of action of KETABETtm (patented combination of ketamine and betaine) in models of depression Repeated use of KETABETtm exhibits potential protective and reversing...

1 2 3 4 5 6 7 8 9 10